Overall, the simultaneous effects of diabetes and obesity on IGF-1 levels are complex, as changes in the GH/IGF-1 axis induced by obesity oppose those triggered by metabolic processes in Type 2 Diabetes Mellitus (T2DM) [20]. The gene discussed is IGF1; the disease is obesity due to melanocortin 4 receptor deficiency.